secwatch.observer — SEC 8-K summary
======================================

Issuer:     CytoDyn Inc. (CYDY)
CIK:        0001175680
Form:       8-K
Filed at:   2022-08-05T23:59:59+00:00
Accession:  0001558370-22-012454
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 4.02
LLM model:  deepseek-v4-flash:cloud@v2

CytoDyn restates FY2021 and five quarterly periods; prior financials no longer reliable
--------------------------------------------------------------------------------

- Audit Committee concludes FY2021 annual and five quarterly periods should not be relied upon.
- Error: convertible note settlements accounted as extinguishments instead of induced conversions.
- Restatement changes non-cash loss on debt settlement, APIC, accumulated deficit, and net loss.
- Estimated understatement of net loss ranges from $2.6M to $24.3M across affected periods.
- Material weakness in internal control over financial reporting identified for 2020-2021 periods.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175680/000155837022012454/0001558370-22-012454-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175680/000155837022012454/cydy-20220804x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-012454

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer